Eventide Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-128,240
| Closed | -$8.57M | – | 133 |
|
|
2016
Q1 | $8.57M | Hold |
128,240
| – | – | 0.48% | 58 |
|
|
2015
Q4 | $8.67M | Sell |
128,240
-53,701
| -30% | -$3.63M | 0.43% | 62 |
|
|
2015
Q3 | $9.72M | Hold |
181,941
| – | – | 0.56% | 55 |
|
|
2015
Q2 | $11.5M | Hold |
181,941
| – | – | 0.62% | 53 |
|
|
2015
Q1 | $8.75M | Sell |
181,941
-58,028
| -24% | -$2.79M | 0.66% | 58 |
|
|
2014
Q4 | $7.97M | Hold |
239,969
| – | – | 0.87% | 52 |
|
|
2014
Q3 | $7.03M | Hold |
239,969
| – | – | 0.98% | 43 |
|
|
2014
Q2 | $9.33M | Buy |
239,969
+2,885
| +1% | +$112K | 1.27% | 36 |
|
|
2014
Q1 | $9.95M | Buy |
237,084
+21,641
| +10% | +$908K | 1.54% | 26 |
|
|
2013
Q4 | $7.07M | Buy |
+215,443
| New | +$7.07M | 2.18% | 11 |
|